CompletedNot Applicable

Closure of Oroantral Fistula (OAF) Using Platelet Rich Fibrin With Middle Meatal Antrostomy

Egypt9 participantsStarted 2023-03-27

Plain-language summary

the study evaluated the one stage endoscopic middle meatal antrostomy (EMMA) technique with the application of a platelet rich fibrin membrane (PRF) for Oroantral Fistula (OAF) closure and relief of maxillary sinusitis.

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. patients who have any systemic disease that contraindicates any intervention under general anesthesia (e.g., coronary artery disease).
✕. OAF that occurred as a result of other causes (e.g., cyst,and trauma)

What they're measuring

Evaluation of the soft tissue wound's healing

Timeframe: 1st, 7th, and14 days postoperatively

Trial details

NCT IDNCT06281873

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-01

View on ClinicalTrials.gov More Oroantral Fistula trials